United Therapeutics, Liquidia Settle Patent Litigation With $330.4M Payment
The settlement includes a $330.4 million aggregate payment to United Therapeutics and actions to remove the PH-ILD indication from Yutrepia’s label.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.